AccuPulse Medical Technology Co., Ltd.
AccuPulse Medical Technology Co., Ltd. (Suzhou AccuPulse, 艾科脉) is a cardiac electrophysiology medical device company in Suzhou Industrial Park, Jiangsu, China, founded in November 2020 to treat atrial fibrillation with non-thermal ablation. It is developing a pulsed electric field ablation (PFA) system — the AccuBlator generator and AccuPulse catheter — using high-voltage fields to induce irreversible electroporation in endocardial cells instead of the thermal injury caused by radiofrequency and cryoablation, plus Accu-System, a 3D cardiac electroanatomic mapping and navigation platform with magnetic/electrical localization and high-channel intracardiac EGM acquisition. The founding team came out of Johnson & Johnson, GE, Abbott, Acutus Medical and MicroPort, with R&D in China and the United States. AccuPulse sells regulated devices to hospitals; it runs no developer program and publishes no public API, SDK or machine-readable API contract on any host it controls.
AccuPulse Medical Technology Co., Ltd. is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Cardiology, and Electrophysiology.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Company 5
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.